HDL—is it too big to fail?

Cholesterol Efflux and Atheroprotection

(2012) Robert S. Rosenson et al.   CIRCULATION

Genetics of Cholesterol Efflux

(2012) Iulia Iatan et al.   Current Atherosclerosis Reports

Rationale for cholesteryl ester transfer protein inhibition

(2012) Bernd Hewing et al.   CURRENT OPINION IN LIPIDOLOGY

HDL functionality

(2012) Handrean Soran et al.   CURRENT OPINION IN LIPIDOLOGY

Dalcetrapib, a cholesteryl ester transfer protein modulator

(2012) Amanda J Hooper et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lipid-Related Markers and Cardiovascular Disease Prediction

(2012)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk

(2012) Philip J. Barter et al.   JOURNAL OF LIPID RESEARCH

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

(2012) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease

(2011) Laura Calabresi et al.   ATHEROSCLEROSIS

HDL-C: Role as a risk modifier

(2011) Philip Barter   ATHEROSCLEROSIS SUPPLEMENTS

Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT

(2011) Ian Tietjen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism

(2011) Eric J. Niesor   CURRENT OPINION IN LIPIDOLOGY

Metabolic and functional relevance of HDL subspecies

(2011) Bela F Asztalos et al.   CURRENT OPINION IN LIPIDOLOGY

Cholesteryl ester transfer protein: The controversial relation to atherosclerosis and emerging new biological roles

(2011) Helena C. F. Oliveira et al.   IUBMB LIFE

The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease

(2011) H. Bryan Brewer   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals

(2011) Christiane L. Haase et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel HDL-directed pharmacotherapeutic strategies

(2011) Emil M. deGoma et al.   Nature Reviews Cardiology

Genetic Variant of the Scavenger Receptor BI in Humans

(2011) Menno Vergeer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

(2010) Margarita de la Llera-Moya et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Recombinant High-Density Lipoprotein Formulations

(2010) Esad Vucic et al.   Current Atherosclerosis Reports

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

(2010) Min Jun et al.   LANCET

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Long-term Benefit of High-Density Lipoprotein Cholesterol–Raising Therapy With Bezafibrate

(2009) Ilan Goldenberg et al.   ARCHIVES OF INTERNAL MEDICINE

Torcetrapib Induces Aldosterone and Cortisol Production by an Intracellular Calcium-Mediated Mechanism Independently of Cholesteryl Ester Transfer Protein Inhibition

(2009) Xiao Hu et al.   ENDOCRINOLOGY

Update on strategies to increase HDL quantity and function

(2009) Danielle Duffy et al.   Nature Reviews Cardiology

The Editor's Roundtable: Lipid Management Beyond Statins—Reducing Residual Cardiovascular Risk

(2008) Vincent E. Friedewald et al.   AMERICAN JOURNAL OF CARDIOLOGY

HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis

(2008) Alan R. Tall et al.   Cell Metabolism

Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity

(2008) Menno Vergeer et al.   CIRCULATION

Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis

(2008) Stephen J. Nicholls et al.   CIRCULATION

High-density lipoproteins, inflammation and oxidative stress

(2008) Fatiha Tabet et al.   CLINICAL SCIENCE

High-density lipoprotein/apolipoprotein A-I infusion therapy

(2008) Jean-Claude Tardif et al.   Current Atherosclerosis Reports

Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease

(2008) Ruth Frikke-Schmidt   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease

(2008) Trine Holm Johannsen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Is raising HDL a futile strategy for atheroprotection?

(2008) Tisha Joy et al.   NATURE REVIEWS DRUG DISCOVERY